BioCentury | Apr 19, 2010
Finance

Codexis decodes cost

...of Maxygen Inc. (NASDAQ:MAXY) in 2002, shareholders include Maxygen (21.4% pre-IPO); Equilon Enterprises (19.8%); the Economic Development Board of Singapore...
BioCentury | Jan 4, 2010
Finance

VCs take over dalbavancin

...NSE:RANBAXY; BSE:500359). Primary shareholders include Maxyge n Inc. (NASDAQ:MAXY; 21.6% pre-IPO); Equilon Enterprises (20%); the Economic Development Board of Singapore...
BioCentury | Jan 4, 2010
Finance

Psychiatry play

...NSE:RANBAXY; BSE:500359). Primary shareholders include Maxyge n Inc. (NASDAQ:MAXY; 21.6% pre-IPO); Equilon Enterprises (20%); the Economic Development Board of Singapore...
BioCentury | Apr 21, 2008
Finance

Ebb & Flow

...had $84.1 million in cash at Dec. 31. Primary shareholders include Maxygen (25.1% pre-IPO); the Economic Development Board of Singapore...
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...H, 2000 DWS Investment GmbH; Stephens; Economic Development Board of Singapore; Sofinov; United Offshore Bank $15M series I, 2001 Economic Development Board of Singapore...
BioCentury | Oct 31, 2001
Financial News

ViaCell raises $15 million

...and neurological diseases, raised $15 million in private financing. Investors included Genzyme Corp. ; the Economic Development Board of Singapore...
BioCentury | Nov 14, 2000
Financial News

ViaCell raises $48 million

...in a mezzanine financing round through Die Wertpapier Spezialisten (DWS); Nomura; The Stephens Group; The Economic Development Board of Singapore...
BioCentury | Oct 23, 2000
Emerging Company Profile

Genomics Collaborative Inc.

...George Soros Special Funds, The Warren Foundation, Whitney & Co., AGTC Funds, Oracle Partners and Economic Development Board of Singapore...
BioCentury | Oct 12, 2000
Financial News

Genomics Collaborative raises $36.2 million

...round. Lead investors included Invesco Private Capital; Whitney & Co; AGTC Funds; Oracle Partners; the Economic Development Board of Singapore...
Items per page:
1 - 9 of 9
BioCentury | Apr 19, 2010
Finance

Codexis decodes cost

...of Maxygen Inc. (NASDAQ:MAXY) in 2002, shareholders include Maxygen (21.4% pre-IPO); Equilon Enterprises (19.8%); the Economic Development Board of Singapore...
BioCentury | Jan 4, 2010
Finance

VCs take over dalbavancin

...NSE:RANBAXY; BSE:500359). Primary shareholders include Maxyge n Inc. (NASDAQ:MAXY; 21.6% pre-IPO); Equilon Enterprises (20%); the Economic Development Board of Singapore...
BioCentury | Jan 4, 2010
Finance

Psychiatry play

...NSE:RANBAXY; BSE:500359). Primary shareholders include Maxyge n Inc. (NASDAQ:MAXY; 21.6% pre-IPO); Equilon Enterprises (20%); the Economic Development Board of Singapore...
BioCentury | Apr 21, 2008
Finance

Ebb & Flow

...had $84.1 million in cash at Dec. 31. Primary shareholders include Maxygen (25.1% pre-IPO); the Economic Development Board of Singapore...
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...H, 2000 DWS Investment GmbH; Stephens; Economic Development Board of Singapore; Sofinov; United Offshore Bank $15M series I, 2001 Economic Development Board of Singapore...
BioCentury | Oct 31, 2001
Financial News

ViaCell raises $15 million

...and neurological diseases, raised $15 million in private financing. Investors included Genzyme Corp. ; the Economic Development Board of Singapore...
BioCentury | Nov 14, 2000
Financial News

ViaCell raises $48 million

...in a mezzanine financing round through Die Wertpapier Spezialisten (DWS); Nomura; The Stephens Group; The Economic Development Board of Singapore...
BioCentury | Oct 23, 2000
Emerging Company Profile

Genomics Collaborative Inc.

...George Soros Special Funds, The Warren Foundation, Whitney & Co., AGTC Funds, Oracle Partners and Economic Development Board of Singapore...
BioCentury | Oct 12, 2000
Financial News

Genomics Collaborative raises $36.2 million

...round. Lead investors included Invesco Private Capital; Whitney & Co; AGTC Funds; Oracle Partners; the Economic Development Board of Singapore...
Items per page:
1 - 9 of 9